Marshall Wace, LLP Alx Oncology Holdings Inc Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 160,059 shares of ALXO stock, worth $235,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,059
Previous 635,679
74.82%
Holding current value
$235,286
Previous $3.83 Million
92.41%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ALXO
# of Institutions
101Shares Held
39.7MCall Options Held
134KPut Options Held
17.4K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$14.3 Million14.51% of portfolio
-
Tang Capital Management LLC San Diego, CA4.2MShares$6.18 Million0.65% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.03MShares$5.93 Million1.07% of portfolio
-
Redmile Group, LLC San Francisco, CA3.84MShares$5.64 Million0.46% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$3.95 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $59.9M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...